Construction and immunogenicity of an mRNA vaccine against chikungunya virus

Chikungunya fever (CHIKF) has spread to more than 100 countries worldwide, with frequent outbreaks in Europe and the Americas in recent years. Despite the relatively low lethality of infection, patients can suffer from long-term sequelae. Until now, no available vaccines have been approved for use;...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jingjing, Lu, Xishan, Li, Xingxing, Huang, Weijin, Fang, Enyue, Li, Wenjuan, Liu, Xiaohui, Liu, Minglei, Li, Jia, Li, Ming, Zhang, Zelun, Song, Haifeng, Ying, Bo, Li, Yuhua
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050897/
https://www.ncbi.nlm.nih.gov/pubmed/37006310
http://dx.doi.org/10.3389/fimmu.2023.1129118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10050897/
https://www.ncbi.nlm.nih.gov/pubmed/37006310
http://dx.doi.org/10.3389/fimmu.2023.1129118

Ejemplares similares